crizanlizumab (Adakveo) Report issue

Biologics mAb Orphan Drug FDA Approved FDA
AACT
Back

Drug Pricing Summary

VA Big4

$176.4250

VA FSS

$233.3450

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
crizanlizumab 10 mg / 1 mL (1 mL INJECTION) $176.4250 VA Big4
  • ADAKVEO (10)
    		•  Novartis Pharmaceuticals Corporation
    crizanlizumab 10 mg / 1 mL (1 mL INJECTION) $233.3450 VA FSS
  • ADAKVEO (10)
    		•  Novartis Pharmaceuticals Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue